News from ViroPharma Incorporated A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 06, 2013, 14:29 ET ViroPharma Announces Upcoming Data Presentations at the 2013 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting

 ViroPharma Incorporated (NASDAQ: VPHM) today announced it will present data relating to the quality of life in patients with Hereditary...


Oct 31, 2013, 07:30 ET ViroPharma Incorporated Reports Third Quarter 2013 Financial Results

ViroPharma Incorporated (Nasdaq: VPHM) reported today its financial results for the third quarter ended September 30, 2013.  Net sales were...


Oct 28, 2013, 12:00 ET ViroPharma To Release 2013 Third Quarter Financial Results On October 31, 2013

ViroPharma Incorporated's (Nasdaq: VPHM) third quarter financial results for 2013 are expected to be released on Thursday, October 31, 2013 before...


Sep 27, 2013, 11:00 ET ViroPharma To Participate In The Leerink Swann Rare Disease Conference

 ViroPharma Incorporated (Nasdaq: VPHM) today announced that the company will present at the Leerink Swann Rare Disease conference at 1:40 PM...


Sep 16, 2013, 02:00 ET ViroPharmas Buccolam® (midazolam munhålelösning) har godkänts för att ingå i läkemedelsförmånerna

ViroPharma Incorporated (Nasdaq: VPHM) meddelade idag att Buccolam® (midazolam munhålelösning) har godkänts av Tandvårds-...


Sep 09, 2013, 15:00 ET ViroPharma To Participate In The Stifel Nicolaus 2013 Healthcare Conference

ViroPharma Incorporated (Nasdaq: VPHM) today announced that the company will present at the Stifel Nicolaus 2013 Healthcare Conference at 8:35 AM...


Aug 01, 2013, 07:30 ET ViroPharma Announces Second Quarter 2013 Financial Results

 VIROPHARMA INCORPORATED (Nasdaq: VPHM) today announced financial results for the second quarter of 2013. Net sales were $104 million for the...


Aug 01, 2013, 07:00 ET ViroPharma Provides Update On Phase 2 Clinical Evaluation Of Subcutaneous Cinryze® (C1 Esterase Inhibitor [Human]) With Recombinant Human Hyaluronidase (rHuPH20)

 ViroPharma Incorporated (NASDAQ: VPHM) today announced that following discussion with the Center for Biologics...


Jul 25, 2013, 13:00 ET ViroPharma To Release 2013 Second Quarter Financial Results On August 1, 2013

ViroPharma Incorporated's (Nasdaq: VPHM) second quarter financial results for 2013 are expected to be released on Thursday, August 1, 2013 before...


Jul 01, 2013, 13:00 ET ViroPharma to Participate in the JMP Securities 2013 Healthcare Conference

 ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present...


Jun 27, 2013, 08:00 ET ViroPharma Provides Update From Ongoing Phase 2 Studies of Maribavir for Treatment of Cytomegalovirus (CMV) Infections

 ViroPharma Incorporated (Nasdaq: VPHM) today announced updated data from the two ongoing, Phase 2 dose ranging studies investigating maribavir...


Jun 19, 2013, 03:00 ET ViroPharmas Buccolam® (midazolam, munnvann, oppløsning) er nå godkjent og tilgjengelig i Norge for akutt behandling av anfall hos barn og ungdom

 ViroPharma Incorporated (Nasdaq: VPHM) melder i dag at Buccolam® (midazolam, munnvann, oppløsning) er godkjent for...


Jun 11, 2013, 03:30 ET ViroPharma Receives Orphan Drug Designation For Maribavir In Europe

ViroPharma Incorporated (Nasdaq: VPHM) today announced that the European Commission has granted orphan drug designation for maribavir for treatment...


May 31, 2013, 14:00 ET ViroPharma To Participate In Several June Healthcare Investor Conferences

 ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present...


May 16, 2013, 01:00 ET ViroPharma er stolt over at bakke op om HAE-dag :-) 2013 og vi hjælper HAE-patienter med at fylde verden med smil

HAE-dagen :-) finder sted 16. maj 2013 og har til formål at øge kendskabet til hereditært angioødem (HAE) Send et smil til...


May 16, 2013, 01:00 ET ViroPharma unterstützt den HAE Day :-) 2013 und bringt zusammen mit HAEi Menschen weltweit zum lächeln

Der HAE Day :-) am 16. Mai 2013 soll das öffentliche Bewusstsein für das hereditäre Angioödem (HAE) schärfen Schicken...


May 09, 2013, 17:00 ET ViroPharma To Participate In Two May Healthcare Investor Conferences

ViroPharma Incorporated (Nasdaq: VPHM) today announced that Robert Doody, director of investor relations, will present at the 2013 Bank of America...


May 01, 2013, 07:30 ET ViroPharma Announces First Quarter 2013 Financial Results

 ViroPharma Incorporated (Nasdaq: VPHM) today announced financial results for the first quarter of 2013. Net sales were $107 million for the...


Apr 25, 2013, 12:00 ET ViroPharma To Release 2013 First Quarter Financial Results On May 1, 2013

ViroPharma Incorporated's (Nasdaq: VPHM) first quarter financial results for 2013 are expected to be released on Wednesday, May 1, 2013 before the...


Apr 22, 2013, 07:30 ET Treatment With VP20621 (Non-Toxigenic Clostridium difficile; NTCD) In A Phase 2 Study Resulted In High Rates Of Colonization And Statistically Significant Reductions In Recurrence Of C. difficile Infection

ViroPharma Incorporated (Nasdaq: VPHM), an international biopharmaceutical company committed to developing and commercializing innovative...


Feb 27, 2013, 07:30 ET ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results

 ViroPharma Incorporated (Nasdaq: VPHM) reported today its financial results for the fourth quarter and year ended December 31, 2012. In 2012,...


Feb 22, 2013, 12:00 ET ViroPharma To Release 2012 Fourth Quarter And Full Year Financial Results On February 27, 2013

 ViroPharma Incorporated's (Nasdaq: VPHM) fourth quarter and full year financial results for 2012 are expected to be released on...


Feb 11, 2013, 12:00 ET ViroPharma To Participate In Two Upcoming Healthcare Investor Conferences

 ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma, will...